GLP-1 weight-loss drugs are reportedly having a significant impact, with some outlets suggesting they are revolutionary. The effects of these drugs may extend beyond weight loss, potentially exposing issues in the US healthcare system and affecting the food industry. There are also indications that access to these drugs may be limited, with some reports of health insurers not covering them, although there are proposals to cut costs and expand access.